GRANDE, VERA
GRANDE, VERA
DIPARTIMENTO DI MEDICINA, CHIRURGIA E ODONTOIATRIA (attivo dal 01/01/1999 al 26/04/2012)
Exploring the role of MKK7 in excitotoxicity and cerebral ischemia : a novel pharmacological strategy against brain injury
2015 A. Vercelli, S. Biggi, A. Sclip, I.E. Repetto, S. Cimini, F. Falleroni, S. Tomasi, R. Monti, N. Tonna, F. Morelli, V. Grande, M. Stravalaci, E. Biasini, O. Marin, F. Bianco, D. di Marino, T. Borsello
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
2014 E. Lesma, S. Ancona, S.M. Sirchia, E. Orpianesi, V. Grande, P. Colapietro, E. Chiaramonte, A.M. Di Giulio, A. Gorio
Un modello di linfangioleiomiomatosi con la somministrazione di cellule muscolari lisce umane TSC2-/-
2010 E. Lesma, E. Chiaramonte, V. Grande, S. Ancona, F. La Briola, M.P. Canevini, M. Corona, F. Ghelma, A.M. Di Giulio, A. Gorio
Characterization of LAM/TSC cells isolated from patient chylous
2010 E. Lesma, S. Ancona, V. Grande, S.M. Sirchia, E. Chiaramonte, S. Bosari, A.M. Di Giulio, A. Gorio
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma
2010 E. Lesma, E. Chiaramonte, V. Grande, S. Ancona, A.M. Di Giulio, A. Gorio
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells
2010 E. Lesma, E. Chiaramonte, S. Ancona, V. Grande, A.M. Di Giulio, A. Gorio
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis
2009 E. Lesma, V. Grande, S. Ancona, E. Chiaramonte, S.M. Sirchia, A.M. Di Giulio, A. Gorio
Role of HMG-CoA reductase inhibitors in controlling TSC2-/- ASM cell growth and proliferation
2009 V. Grande, E. Lesma, S. Ancona, E. Chiaramonte, A.M. Di Giulio, A. Gorio
An epigenetic event may underlies the TSC features in TSC2 ASM cells
2009 E. Lesma, S. Ancona, S.M. Sirchia, V. Grande, E. Chiaramonte, S. Bosari, A.M. Di Giulio, A. Gorio
Promoter methylation of TSC2 gene is important for pathogenesis of TSC and LAM lesions
2009 S. Ancona, E. Lesma, S.M. Sirchia, V. Grande, E. Chiaramonte, A.M. Di Giulio, A. Gorio
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair
2009 E. Lesma, E. Chiaramonte, S. Ancona, V. Grande, R. Adami, A.M. Di Giulio, A. Gorio
Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM
2008 E. Lesma, V. Grande, S. Ancona, A.M. Di Giulio, A. Gorio
Development of a LAM model by using human TSC2-/- cells derived from a renal angiomyolipoma : A pharmacological evaluation
2008 E. Lesma, E. Isaia, S. Ancona, V. Grande, A.M. Di Giulio, A. Gorio
Farmacologia
2008 E.A. Lesma, A. Gorio, D. Bottai, S. Carelli, V. Grande, A.M. Di Giulio
Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2-/- Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM
2008 E. Lesma, V. Grande, S. Ancona, S. Carelli, A.M. Di Giulio, A. Gorio
Proliferation and invasiveness of human smooth muscle TSC2-/- : Effect of anti-EGFR and rapamycin
2007 A.M. Di Giulio, E. Isaia, V. Grande, E. Lesma, A. Gorio
Expression of the anti-apoptotic protein survivin amd altered function of IGF-1 pathway in TSC2 brain tubers
2007 V. Grande, E. Lesma, E. Isaia, L. Madaschi, M.P. Canevini, L. Tassi, A.M. Di Giulio, A. Gorio
Survivin expression in tuberous sclerosis complex cells
2007 S. Carelli, E. Lesma, S. Paratore, V. Grande, G. Zadra, S. Bosari, A.M. Di Giulio, A. Gorio
Reversion of the phenotype of human TSC2-/- smooth muscle cells
2007 E. Lesma, V. Grande, E. Isaia, A.M. Di Giulio, A. Gorio
Phenotype reversion of human TSC2-/- smooth muscle cells
2007 E. Lesma, V. Grande, E. Isaia, A.M. Di Giulio, A. Gorio